- Discussion of rare adenovirus-vector COVID-vaccine side effect: STAT News article on blood-clot incidence (~1 in 1 million) framed as low absolute risk.  
- DARPA selects Blue Origin and Lockheed Martin to develop a nuclear-thermal spacecraft for an in-space propulsion demonstration mission.  
- Transhumanist timeline debate sparked by link to “Two Paths to the Future,” a blog post analyzing windows for achieving radical life-extension and intelligence amplification.  
- Oligonucleotide synthesis hardware comparison:  
  – Azco Biotech’s discontinued electrochemical parallel synthesizer (OligoArray) recalled as a high-throughput 10-year-old platform.  
  – Current interest in Biolytic Dr. Oligo systems and desire for low-consumable, non-chip-based enzymatic or chemical synthesis solutions.  
- Energy context: global power demand rising ~2.25–2.5 % per year, with tongue-in-cheek calls for Dyson-swarm deployment.  
- Shared YouTube link to a “self-transforming robot” video jokingly described as using “neuro-resonant frequencies” to influence consumer behavior.